Covered recipient · General Payments record
KELLY M DEVOOGD
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Obstetrics
General Payments · PY2019–2025
$1,543.12
- Reported across 58 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.35 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | $124.08 | 1 |
| Corcept Therapeutics | $35.13 | 2 |
| Lilly USA, LLC | $33.34 | 2 |
| Exact Sciences Corporation | $30.43 | 1 |
| Organon LLC | $25.91 | 2 |
| Lundbeck LLC | $22.02 | 1 |
| Axsome Therapeutics, Inc. | $20.50 | 1 |
| GlaxoSmithKline, LLC. | $19.26 | 1 |
| Novo Nordisk AS | $18.57 | 1 |
| ITI, Inc. | $17.47 | 1 |
| ABBVIE INC. | $16.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.64 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201758466 | CMS |
| Axsome Therapeutics, Inc. | $20.50 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235544728 | CMS |
| Corcept Therapeutics | $14.33 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214240562 | CMS |
| Corcept Therapeutics | $20.80 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214240642 | CMS |
| Exact Sciences Corporation | $30.43 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235592335 | CMS |
| GlaxoSmithKline, LLC. | $19.26 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190835885 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.47 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241293078 | CMS |
| Lilly USA, LLC | $18.52 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186748861 | CMS |
| Lilly USA, LLC | $14.82 | 06/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186658075 | CMS |
| Lundbeck LLC | $22.02 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251789581 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $124.08 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254645876 | CMS |
| Novo Nordisk Inc | $18.57 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188840266 | CMS |
| Organon LLC | $19.50 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237774138 | CMS |
| Organon LLC | $6.41 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237774136 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.